Medical Oncology

VEXAS

Questions discussed in this category

For patients with VEXAS syndrome and good response to azacitidine, what duration of therapy do you consider?

How do you decide to trial a patient off treatment? When do you consider spacing therapy and at what frequency?

1 Answer available

Papers discussed in this category

Blood, 2022 Aug 25

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.

Annals of the rheumatic diseases, 2024 Sep 30

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.

Related Topics in Medical Oncology